(Q43777416)

26 November 2017

Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma (English)

1 reference

chronic obstructive pulmonary disease

26 November 2017

1 reference

1 reference

1 reference

1 reference

Eugene Kotlyar

1

1 reference

26 November 2017

Anne M Keogh

2

1 reference

26 November 2017

Peter S Macdonald

3

1 reference

26 November 2017

Ruth H Arnold

4

1 reference

26 November 2017

Dermot J McCaffrey

5

1 reference

26 November 2017

Allan R Glanville

6

1 reference

26 November 2017

1 December 2002

1 reference

The Journal of Heart and Lung Transplantation

26 November 2017

1 reference

26 November 2017

21

1 reference

26 November 2017

12

1 reference

26 November 2017

1290-1295

1 reference

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900459-X

7 January 2021

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900459-X

7 January 2021

The lungs in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900459-X

7 January 2021

Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900459-X

7 January 2021

Effects of severity of long-standing congestive heart failure on pulmonary function

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900459-X

7 January 2021

Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900459-X

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900459-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900459-X

1 reference

7 January 2021

Diffusing capacity decreases after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900459-X

7 January 2021

Utility of peak expiratory flow monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900459-X

7 January 2021

Adrenoceptors in airway smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900459-X

7 January 2021

Some bronchoconstricting and bronchodilating responses of human isolated bronchi: evidence for the existence of -adrenoceptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900459-X

7 January 2021

Thymoxamine and airways obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900459-X

7 January 2021

The airways response to phenylephrine after blockade of alpha and beta receptors in extrinsic bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900459-X

7 January 2021

10.1016/S1053-2498(02)00459-X

Identifiers

DOI

1 reference

26 November 2017

1 reference